Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c646f75c4f7c6349f35c8fe01934921 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-221 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 |
filingDate |
2001-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2007-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2712fbc3311f345d75951db2e53f13c |
publicationDate |
2007-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2269356-T3 |
titleOfInvention |
COMPOSITION THAT CONSISTS OF PROPIONIL L-CARNITINE AND GLYCINE FOR THE PREVENTION AND / OR TREATMENT OF CITOTOXIC EFFECTS INDUCED BY THE USE OF IMMUNOSUPPRESSING AGENTS. |
abstract |
A combination composition consisting of: a) propionyl L-carnitine or a pharmacologically acceptable salt thereof; and b) glycine, or a pharmacologically acceptable salt thereof. |
priorityDate |
2000-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |